Evolus Shares Outstanding 2016-2025 | EOLS
Evolus shares outstanding from 2016 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Evolus Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 62 |
| 2023 | 57 |
| 2022 | 56 |
| 2021 | 50 |
| 2020 | 34 |
| 2019 | 28 |
| 2018 | 24 |
| 2017 | 17 |
| 2016 | 17 |
| 2015 | 17 |
| Evolus Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 64 |
| 2024-12-31 | 62 |
| 2024-09-30 | 63 |
| 2024-06-30 | 63 |
| 2024-03-31 | 59 |
| 2023-12-31 | 57 |
| 2023-09-30 | 57 |
| 2023-06-30 | 57 |
| 2023-03-31 | 56 |
| 2022-12-31 | 56 |
| 2022-09-30 | 56 |
| 2022-06-30 | 56 |
| 2022-03-31 | 56 |
| 2021-12-31 | 50 |
| 2021-09-30 | 55 |
| 2021-06-30 | 51 |
| 2021-03-31 | 41 |
| 2020-12-31 | 34 |
| 2020-09-30 | 34 |
| 2020-06-30 | 34 |
| 2020-03-31 | 34 |
| 2019-12-31 | 28 |
| 2019-09-30 | 27 |
| 2019-06-30 | 27 |
| 2019-03-31 | 27 |
| 2018-12-31 | 24 |
| 2018-09-30 | 25 |
| 2018-06-30 | 24 |
| 2018-03-31 | 20 |
| 2017-12-31 | 18 |
| 2017-09-30 | 17 |
| 2017-06-30 | 17 |
| 2017-03-31 | 17 |
| 2016-12-31 | |
| 2015-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.620B | $0.266B |
| Evolus, Inc. is a medical aesthetics company. It focuses on providing physicians and patients in aesthetic procedures and treatments. The company focuses on the self-pay aesthetic market and its lead product candidate, DWP-450, is an injectable 900 kDa purified botulinum toxin type A complex. Evolus, Inc. is based in Irvine, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $240.237B | 28.89 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $147.507B | 30.84 |
| EssilorLuxottica (ESLOY) | France | $130.320B | 0.00 |
| Medtronic (MDT) | Ireland | $110.401B | 15.65 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.194B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.171B | 26.90 |
| ResMed (RMD) | United States | $37.523B | 28.18 |
| Agilent Technologies (A) | United States | $33.417B | 21.78 |
| GE HealthCare Technologies (GEHC) | United States | $32.959B | 15.65 |
| Terumo (TRUMY) | Japan | $27.294B | 35.45 |
| Koninklijke Philips (PHG) | Netherlands | $23.014B | 16.15 |
| Insulet (PODD) | United States | $21.880B | 85.88 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.269B | 11.73 |
| Baxter (BAX) | United States | $15.698B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.073B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.474B | 22.53 |
| Lantheus Holdings (LNTH) | United States | $5.601B | 14.13 |
| Prestige Consumer Healthcare (PBH) | United States | $4.184B | 18.69 |
| Perrigo (PRGO) | Ireland | $3.678B | 9.32 |
| Haemonetics (HAE) | United States | $3.510B | 15.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.221B | 23.75 |
| Envista Holdings (NVST) | United States | $3.210B | 26.68 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| QuidelOrtho (QDEL) | United States | $1.939B | 13.34 |
| LeMaitre Vascular (LMAT) | United States | $1.916B | 42.83 |
| AtriCure (ATRC) | United States | $1.621B | 0.00 |
| Acuren (TIC) | United States | $1.311B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.182B | 12.00 |
| Neogen (NEOG) | United States | $1.070B | 13.69 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.004B | 12.83 |
| Kestra Medical Technologies (KMTS) | United States | $0.906B | 0.00 |
| InMode (INMD) | Israel | $0.870B | 8.76 |
| CeriBell (CBLL) | United States | $0.710B | 0.00 |
| Owens & Minor (OMI) | United States | $0.578B | 4.79 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.568B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.519B | 0.00 |
| Valneva SE (VALN) | France | $0.477B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.423B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.328B | 12.05 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.10 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.22 |
| Brainsway (BWAY) | Israel | $0.232B | 61.30 |
| Canopy Growth (CGC) | Canada | $0.230B | 0.00 |
| Quanterix (QTRX) | United States | $0.229B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.224B | 66.33 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.74 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.131B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.84 |
| Jin Medical (ZJYL) | China | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| MacroGenics (MGNX) | United States | $0.085B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 59.43 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.89 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |